| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $15K | -57.5% |
| R&D Expense | $641K | +2101.6% |
| SG&A Expense | $5.0M | -38.5% |
| Operating Income | -$6.5M | +22.5% |
| Interest Expense | $15K | -20.6% |
| Pre-tax Income | -$6.5M | +22.5% |
| Net Income | -$6.5M | +22.5% |
| EPS (Basic) | -$3.71 | -1096.8% |
| EPS (Diluted) | -$3.71 | -1096.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Accounts Receivable | $8K | -56.3% |
| Current Assets | $5.9M | -32.6% |
| Total Assets | $7.8M | -26.8% |
| Current Liabilities | $605K | -4.3% |
| Total Liabilities | $793K | -25.0% |
| Stockholders' Equity | $7.0M | -27.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | -14.7% |
| Capital Expenditures | $187K | -12.8% |
| Investing Cash Flow | -$419K | -3.7% |
| Financing Cash Flow | $3.4M | -71.3% |
| Free Cash Flow | -$5.9M | -13.6% |